Zepbound, Mounjaro sales buoy Eli Lilly family endowment
by
Contributor since / Followers
Contributor since / Followers
1 month ago
wellesenterprises
- Sales of Eli Lilly’s blockbuster GLP-1/GIP meds Zepbound and Mounjaro, which contain tirzepatide and are approved for, respectively, weight loss and type 2 diabetes, have helped to majorly boost the drugmaker’s founders family endowment.
- The Lilly Endowment’s assets have grown